文献速递糖尿病肥胖与代谢综合征

术前缓解评分与糖尿病病程对减重术后2型糖尿病持久缓解及并发症风险的预测比较:瑞典肥胖受试者研究的事后分析

Comparison of Preoperative Remission Scores and Diabetes Duration Alone as Predictors of Durable Type 2 Diabetes Remission and Risk of Diabetes Complications After Bariatric Surgery: A Post Hoc Analysis of Participants From the Swedish Obese Subjects Study.
PubMed 文献 · Diabetes Care · 2020-09-01

该研究基于瑞典肥胖受试者研究手术组363例术前2型糖尿病患者,比较ABCD、DiaRem等缓解评分与糖尿病病程对减重术后短期及持久缓解和并发症的预测能力。结果显示各评分与病程对2年缓解预测良好(AUROC 0.79-0.88 vs 0.84),但对10年持久缓解预测下降(0.70-0.76 vs 0.73),对15年并发症预测有限。

要点

  • 缓解评分与糖尿病病程对减重术后2年糖尿病缓解预测良好。
  • 对10年持久缓解,各评分预测能力下降,未优于糖尿病病程。
  • 对15年糖尿病并发症,缓解评分与病程预测能力均有限。

核心结论

  • 缓解评分和糖尿病病程是短期糖尿病缓解的良好预测指标,但对持久缓解和并发症风险预测能力有限。

研究设计与样本

  • 前瞻性瑞典肥胖受试者研究的事后分析,纳入手术组363例术前2型糖尿病且数据完整者。

主要发现

  • 2年缓解AUROC:缓解评分0.79-0.88,糖尿病病程0.84。
  • 10年缓解AUROC:缓解评分0.70-0.76,糖尿病病程0.73。
  • 15年微血管并发症AUROC:缓解评分0.70-0.80,糖尿病病程0.77。
  • 15年大血管并发症AUROC:缓解评分0.62-0.71,糖尿病病程0.66。

关键数值与推荐

  • 部分缓解定义为血糖<6.1 mmol/L或HbA1c<6.5%(48 mmol/mol)且无糖尿病药物治疗(术后2年和10年评估)。

临床怎么用

  • 缓解评分和糖尿病病程可用于术前短期缓解预测,但对持久缓解和并发症风险预测价值有限,需综合评估。

局限性

  • 事后分析,仅纳入手术组数据完整者,可能影响代表性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Bariatric surgery is associated with diabetes remission and prevention of diabetes-related complications. The ABCD, DiaRem, Ad-DiaRem, DiaBetter, and individualized metabolic surgery scores were developed to predict short- to medium-term diabetes remission after bariatric surgery. However, they have not been tested for predicting durable remission nor the risk of diabetes complications, nor compared with diabetes duration alone. RESEARCH DESIGN AND METHODS: We identified 363 individuals from the surgically treated group in the prospective Swedish Obese Subjects study with preoperative type 2 diabetes and for whom data (preoperative age, BMI, C-peptide, HbA1c, oral diabetes medications, insulin use, and diabetes duration) were available for calculation of remission scores. Partial remission (after 2 and 10 years) was defined as blood glucose <6.1 mmol/L or HbA1c <6.5% (48 mmol/mol) and no diabetes medication. Information on diabetes complications (at baseline and over 15 years of follow-up) was obtained from national health registers. Discrimination was evaluated by area under receiver operating characteristic curves (AUROCs). RESULTS: For 2-year diabetes remission, AUROCs were between 0.79 and 0.88 for remission scores and 0.84 for diabetes duration alone. After 10 years, the predictive ability of scores decreased markedly (AUROCs between 0.70 and 0.76), and no score had higher predictive capacity than diabetes duration alone (AUROC = 0.73). For development of microvascular and macrovascular diabetes complications over 15 years, AUROCs for remission scores were 0.70-0.80 and 0.62-0.71, respectively, and AUROCs for diabetes duration alone were 0.77 and 0.66, respectively. CONCLUSIONS: Remission scores and diabetes duration are good predictors of short-term diabetes remission. However, for durable remission and risk of complications, remission scores and diabetes duration alone have limited predictive ability.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Sjöholm K, Carlsson LMS, Taube M, et al. Comparison of Preoperative Remission Scores and Diabetes Duration Alone as Predictors of Durable Type 2 Diabetes Remission and Risk of Diabetes Complications After Bariatric Surgery: A Post Hoc Analysis of Participants From the Swedish Obese Subjects Study. Diabetes Care. 2020. PMID: 32873586. doi:10.2337/dc20-0157

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。